Mouse Subrenal Capsule Assay Chemosensitivity and DNA Flow Cytometry Parameters of Human Melanoma Metastases

References

• Koh H K. Cutaneous melanoma. N Engl J Med 1991; 352(3)171–182
   Web of Science ®Google Scholar
• Bogden A E, Kelton D E, Cobb W R, Esber H J. A rapid screening method for testing chemotherapeutic agents against human tumor xenografts. Proceedings of a Symposium on the Use of Athymic (Nude) Mice in Cancer Research, D P Houchens, A A Ovejara. Fisher, New York 1978; 231–50
   Google Scholar
• Bogden A E, Cobb W R, Le Page D J. Chemotherapy responsiveness of human tumors as first transplant generation in the normal mouse: six day subrenal capsule assay. Cancer 1981; 48: 10–20
   PubMed Web of Science ®Google Scholar
• Marek J, Bechyne M. The subrenal capsule assay in immuno-competent mice—the inevitable role of histopathology in assessment of this method as a tool determining tumor sensitivity to cytostatic drugs. Neoplasma 1990; 37: 23–30
   PubMed Web of Science ®Google Scholar
• Edelstein M B, Stnink T, Ruiter D J, Visser W, Van Putten L M. Improvements and limitations of the subrenal capsule assay for determing tumour sensitivity to cytostatic drugs. Eur J Cancer Clin Oncol 1984; 20: 1549–56
   PubMedGoogle Scholar
• Venesmaa P, Ylikorkala O. Subrenal capsule assay in selection of chemotherapy after operation for recurrent ovarian cancer. Br J Cancer 1991; 63: 84–6
   PubMed Web of Science ®Google Scholar
• Pyrhönen S, Hahka-Kemppinen M, Muhonen T. A promising interferon plus four-drug chemotherapy regimen for metastatic melanoma. J Clin Oncol 1992; 10: 1919–26
   PubMed Web of Science ®Google Scholar
• Muhonen T, Pyrhönen S, Laasonen A, Asko-Seljavaara S, Franssila K. DNA aneuploidy and low S-phase fraction as favourable prognostic signs in metastatic melanoma. Br J Cancer 1991; 64: 749–52
   PubMed Web of Science ®Google Scholar
• Mäenpää J, Grönroos M, Leppänen M, Kangas L. The subrenal capsule assay in mice. Prediction of rat tumor sensitivity to chemotherapy. Cancer 1984; 54: 1530–4
   PubMed Web of Science ®Google Scholar
• Slagel D E, De Simone P, Dillon H, Le Page D J, Bogden A E. Subrenal capsule assay: feasibility of transporting tissues to a central facility for testing. Cancer Treat Rep 1985; 69: 717–8
   PubMedGoogle Scholar
• Vindeløv L L, Christensen I J, Nissen N I. A detergent trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry 1983; 3: 323–7
   PubMedGoogle Scholar
• Kouri M, Laasonen A, Mecklin J-P, Järvinen H, Franssila K, Pyrhönen S. Diploid predominance in hereditary nonpolypo-sis colorectal carcinoma evaluated by flow cytometry. Cancer 1990; 65: 1825–9
   PubMed Web of Science ®Google Scholar
• Pyrhönen S, Laasonen A, Tammilehto L. Diploid predominance and prognostic significance of S-phase cells in malignant mesothelioma. Eur J Cancer 1991; 27: 197–200
   PubMed Web of Science ®Google Scholar
• Look A T, Hayes M, Nitscke R, McWilliams N B, Green A A. Cellular DNA content as a predictor of response to chemotherapy in infants with unresectable neuroblastoma. N Engl JMed 1984; 311: 231–5
   PubMed Web of Science ®Google Scholar
• Smets L A, Homan-Blok J, Hart A. Prognostic implication of hyperdiploidy as based on DNA flow cytometric measurements in childhood acute lymphocytic leukemia—a multicenter study. Leukemia 1987; 1: 163–6
   PubMed Web of Science ®Google Scholar
• Abe S, Tsuneta Y, Makimura S, Itabashi K, Nagai T, Kawakami Y. Nuclear DNA content as an indicator of chemosensitivity in small-cell carcinoma of the lung. Anal Quant Cytol Histol 1987; 9: 425–8
   PubMed Web of Science ®Google Scholar
• Briffod M, Spyratos F, Tubiana-Hulin. Sequential cytop-unctures during preoperative chemotherapy for primary breast carcinoma. Cytomorphologic changes, initial tumor ploidy, and tumor regression. Cancer 1989; 63: 631–7
   PubMed Web of Science ®Google Scholar
• Hedley D W, Rugg C A, Ng A B, Taylor I W. Influence of cellular DNA content on disease-free survival of stage II breast cancer patients. Cancer Res 1984; 44: 5395–8
   PubMed Web of Science ®Google Scholar
• Campbell B H, Schemmel J C, Hopwood L E, Hoffmann R G. Flow cytometric evaluation of chemosensitive and chemo-resistant head and neck tumors. Am J Surg 1990; 160: 424–6
   PubMed Web of Science ®Google Scholar
• Cooke L D, Cooke T G, Bootz F. Ploidy as a prognostic indicator in end stage squamous cell carcinoma of the head and neck region treated with cisplatinum. Br J Cancer 1990; 61: 759–62
   PubMed Web of Science ®Google Scholar
• Hemmer J, Kreidler J, Thein T, Haase S. Monitoring of intra-arterial treatment with epirubicin and cisplatin in oral carcinoma by DNA flow cytometry. Chemotherapy 1991; 37: 150–6
   PubMed Web of Science ®Google Scholar
• Bösing T, Roessner A, Hiddemann W, Mellin W, Grundmann E. Cytostatic effects in osteosarcomas as detected by flow cytometric DNA analysis after preoperative chemotherapy according to the COSS 80/82 protocol. J Cancer Res Clin Oncol 1987; 113: 369–75
   PubMed Web of Science ®Google Scholar
• Look A T, Douglass E C, Meyer W H. Clinical importance of near-diploid tumor stem lines in patients with osteosarcoma of an extremity. N Engl J Med 1988; 318: 1567–72
   PubMed Web of Science ®Google Scholar
• Shaaban A A, Tribukait B, el-Bedeiwy A F, Ghoneim M A. Prediction of lymph node metastases in bladder carcinoma with deoxyribonucleic acid flow cytometry. J Urol 1990; 144: 884–7
   PubMed Web of Science ®Google Scholar
• Feichter G E, Maier H, Adler D. S-phase fractions and DNA-ploidy of oropharyngeal squamous epithelium carcinomas compared with histologic grade, stage, response tho chemotherapy and survival. Acta Otolanryngol (Stockh) 1987; 104: 377–84
   PubMed Web of Science ®Google Scholar
• Remvikos Y, Beuzeboc P, Zajdela A, Voillemot N, Magdele-Nat H, Pouillart P. Correlation of pretreatment proliferative activity of breast cancer with the response to cytotoxic chemotherapy. J Natl Cancer Inst 1989; 81: 1383–7
   PubMed Web of Science ®Google Scholar
• Volm M, Drings P, Mattern J, Sonka J, Vogt-Moykopf I, Wayss K. Prognostic significance of DNA patterns and resistance-predictive tests in non-small cell lung carcinoma. Cancer 1985; 56: 1396–403
   PubMed Web of Science ®Google Scholar
• Volm M, Efferth T. Relationship of DNA ploidy to chemore-sistance of tumors as measured by in vitro tests. Cytometry 1990; 11: 406–10
   PubMedGoogle Scholar
• Tueni E A, Dumont P, Jacobovit D. Subrenal capsule assay for fresh human tumors in immunocompetent mice; an inappropriate technique for non-small cell lung cancer. Eur J Cancer Clin Oncol 1987; 23: 1163–7
   PubMedGoogle Scholar
• Kouri M, Pyrhönen S, Kangas L. Growth of human colorectal carcinoma implants in the mouse subrenal capsule assay. Ann Chir Gynaecol 1989; 78: 110–4
   PubMedGoogle Scholar
• Dumont P, van der Esch E P, Jabri M, Lejeune F, Atassi G. Chemosensitivity of human xenografts in immunocompetent mice and its histological evaluation. Int J Cancer 1984; 33: 447–51
   PubMed Web of Science ®Google Scholar
• Kallioniemi O P. DNA flow cytometry in oncology-methodology and prognostic value in breast and ovarian cancer. Acta Universitatis Temperensis SerA 1988; 249: 1–90
   Google Scholar
• Fuhr J E, Frye A, Kattine A A, Van Meter S. Flow cytometric determination of breast tumor heterogeneity. Cancer 1991; 67: 1401–5
   PubMed Web of Science ®Google Scholar